DACARBAZINE
Generic: DACARBAZINE
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
DACARBAZINEActive Substance
2001-06-15Original Approval
DACARBAZINE is FDA application ANDA075812, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FEBRILE NEUTROPENIA
643 reports
2
OFF LABEL USE
613 reports
3
NEUTROPENIA
504 reports
4
PYREXIA
387 reports
5
DRUG INEFFECTIVE
335 reports
6
DISEASE PROGRESSION
313 reports
7
NEUROPATHY PERIPHERAL
300 reports
8
NAUSEA
280 reports
9
ANAEMIA
254 reports
10
PRODUCT USE IN UNAPPROVED INDICATION
239 reports